Edition:
United Kingdom

Aslan Pharmaceuticals Ltd (ASLN.OQ)

ASLN.OQ on NASDAQ Stock Exchange Global Market

4.01USD
18 Apr 2019
Change (% chg)

-- (--)
Prev Close
$4.01
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
4,980
52-wk High
$10.41
52-wk Low
$2.52

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec '18 0.00 -2.144
Sep '18 0.00 -2.134
Jun '18 0.00 -2.233
Mar '18 0.00 -1.959
FY 2017 Dec '17 0.00 -3.358
Sep '17 0.00 -1.851
Jun '17 0.00 -2.299
Mar '17 0.00 -2.169
 
*Note: Units in Millions ofTaiwanese Dollars
**Note: Units in Taiwanese Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 62.06 62.40
P/E High - Last 5 Yrs. -- 49.30 56.31
P/E Low - Last 5 Yrs. -- 27.69 28.72
Beta -- 0.93 0.93
Price to Sales (TTM) -- 7.53 9.62
Price to Book (MRQ) 4.16 3.96 4.53
Price to Tangible Book (MRQ) 16.90 7.02 7.71
Price to Cash Flow (TTM) -- 43.56 43.23
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.69 1.54
Dividend Yield - 5 Year Avg -- 0.70 0.70
Dividend 5 Year Growth Rate -- 2.09 2.97
Payout Ratio(TTM) -- 21.48 21.72

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 7.67 9.20
Sales (TTM) vs TTM 1 Yr. Ago -- 4.62 8.35
Sales - 5 Yr. Growth Rate -- 9.81 11.12
EPS (MRQ) vs Qtr. 1 Yr. Ago 36.15 137.79 110.61
EPS (TTM) vs TTM 1 Yr. Ago 12.47 -- --
EPS - 5 Yr. Growth Rate -- 5.17 6.92
Capital Spending - 5 Yr. Growth Rate 74.60 6.57 7.61

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.67 2.66
Current Ratio (MRQ) 3.64 3.69 3.63
LT Debt to Equity (MRQ) 45.64 12.46 13.26
Total Debt to Equity (MRQ) 45.64 15.13 16.97
Interest Coverage (TTM) -47.39 30.53 27.27

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 51.66 50.31
Gross Margin - 5 Yr. Avg. -- 49.84 50.77
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 17.18 15.78
Operating Margin (TTM) -- 3.40 -2.09
Operating Margin - 5 Yr. Avg. -- 13.49 11.11
Pre-Tax Margin (TTM) -- 2.52 -2.92
Pre-Tax Margin - 5 Yr. Avg. -- 20.30 16.76
Net Profit Margin (TTM) -- -1.27 -6.86
Net Profit Margin - 5 Yr. Avg. -- 15.16 11.72
Effective Tax Rate (TTM) -- 22.76 22.86
Effective Tax Rate - 5 Yr. Avg. -- 23.62 23.86

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 905,177,527 773,166,387
Net Income/Employee (TTM) -- 104,261,468 89,056,262
Receivable Turnover (TTM) -- 5.42 5.22
Inventory Turnover (TTM) -- 2.62 3.65
Asset Turnover (TTM) 0.00 0.84 0.81

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -80.99 9.94 9.54
Return on Assets - 5 Yr. Avg. -- 11.04 10.49
Return on Investment (TTM) -93.56 12.17 11.78
Return on Investment - 5 Yr. Avg. -- 14.08 13.39
Return on Equity (TTM) -127.80 13.11 12.61
Return on Equity - 5 Yr. Avg. -- 15.31 14.86
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 12.61 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aslan Pharmaceuticals Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 1.86%
# of Holders: 3
Total Shares Held: 2,981,300
3 Mo. Net Change: 142,000
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 1
# Reduced Positions: 0
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.